Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

WLLW

Willow Biosciences (WLLW)

Willow Biosciences Inc
일자:
정렬 기준:
 검색 관련기사 보기:TSX:WLLW
일자시간출처헤드라인심볼기업
2024/11/1221:00PR Newswire (Canada)WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
2024/11/1221:00PR Newswire (US)WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
2024/11/0721:00PR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIOTSX:WLLWWillow Biosciences Inc
2024/11/0721:00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIOTSX:WLLWWillow Biosciences Inc
2024/09/1908:00PR Newswire (Canada)WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
2024/09/1908:00PR Newswire (US)WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
2024/09/0602:00AllPennyStocks.comBiotech on An Upswing Following Licensing and Royalty AgreementTSX:WLLWWillow Biosciences Inc
2024/09/0520:00PR Newswire (US)WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.TSX:WLLWWillow Biosciences Inc
2024/09/0520:00PR Newswire (Canada)WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.TSX:WLLWWillow Biosciences Inc
2024/08/1220:00PR Newswire (US)WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
2024/08/1220:00PR Newswire (Canada)WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
2024/08/0720:00PR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDYTSX:WLLWWillow Biosciences Inc
2024/08/0720:00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDYTSX:WLLWWillow Biosciences Inc
2024/07/2706:48PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTSTSX:WLLWWillow Biosciences Inc
2024/07/1821:49PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF UNITSTSX:WLLWWillow Biosciences Inc
2024/06/2705:30PR Newswire (Canada)WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAMTSX:WLLWWillow Biosciences Inc
2024/06/2705:30PR Newswire (US)WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAMTSX:WLLWWillow Biosciences Inc
2024/06/0320:00PR Newswire (Canada)WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLIONTSX:WLLWWillow Biosciences Inc
2024/05/3020:00PR Newswire (US)WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
2024/05/3020:00PR Newswire (Canada)WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
2024/05/1320:00PR Newswire (US)WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
2024/05/1320:00PR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
2024/03/2908:30PR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFTSX:WLLWWillow Biosciences Inc
2024/03/2908:30PR Newswire (US)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFTSX:WLLWWillow Biosciences Inc
2024/03/0108:00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECTSX:WLLWWillow Biosciences Inc
2024/03/0108:00PR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECTSX:WLLWWillow Biosciences Inc
2024/02/2108:00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSTSX:WLLWWillow Biosciences Inc
2024/02/2108:00PR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSTSX:WLLWWillow Biosciences Inc
2024/01/3121:00PR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
2024/01/3121:00PR Newswire (Canada)WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
 검색 관련기사 보기:TSX:WLLW